Dose Optimization: Getting it Right for Vulnerable Populations
By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…
CertaraMay 22, 2023
Japan’s Approach to Pediatric Drug Development: What You Need to Know
Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…
CertaraMay 22, 2023
Creation of a Scientific Hypothesis – For optimization of drug compounds | Chemaxon
A well-formulated hypothesis is essential to the success of the drug discovery process.
CertaraMay 19, 2023
Key Properties in Drug Design | Predicting Lipophilicity, pKa and Solubility
Discover how Chemaxon's predictive models for lipophilicity, pKa, and solubility can accurately predict key molecular…
CertaraMay 12, 2023
Certara’s Synchrogenix Writer now enhanced with AI Layar
Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…
CertaraMay 11, 2023
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease
RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…
CertaraMay 9, 2023
The Impact of the Inflation Reduction Act on Biosimilar Uptake
In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…
CertaraMay 8, 2023
What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch?
A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…
CertaraMay 4, 2023
